AstraZeneca, Transgene team up on viral immunotherapies

Note: This section contains information in English only.
Source: Dukascopy Bank SA
The UK drugmaker AstraZeneca tied up with the French biopharmaceutical company Transgene by signing a deal on Thursday to develop five viral immunotherapies aimed at killing cancer.

Actual Topics